New antimetabolites in cancer chemotherapy and their clinical impact
1998
New Antimetabolites in Cancer Chemotherapy
publication
Evidence: moderate
Author Information
Author(s): SB Kaye
Primary Institution: Cancer Research Campaign Department of Medical Oncology, Beatson Oncology Centre
Conclusion
New antimetabolites show promise in improving cancer treatment outcomes.
Supporting Evidence
- Antimetabolites have been used for 50 years in cancer treatment.
- New agents like gemcitabine and capecitabine are showing effectiveness in various cancers.
- Thymidylate synthase inhibitors are a focus of recent research.
Takeaway
Scientists are finding new medicines to help fight cancer by stopping cancer cells from growing.
Limitations
The review does not cover every antimetabolite and focuses on the most interesting examples.
Want to read the original?
Access the complete publication on the publisher's website